NEOCELLA
LIVE

Serial Number

79364057

Owner

NEOCELLA INC.

Attorney

Kisuk Lee

Filing Date

Dec 2, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEOCELLA Trademark

Serial Number: 79364057 • Registration: 7483879

NEOCELLA is a trademark filed by NEOCELLA INC. on December 2, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NEOCELLA INC. (2 trademarks)

10 Corporate Park, Suite 210

Entity Type: 03

Trademark Details

Filing Date

December 2, 2022

Registration Date

August 27, 2024

Published for Opposition

June 11, 2024

Goods & Services

Veterinary preparations for oncology, cancers; vaccines; non-prescription medicines for oncology, cancers; contrast media for in vivo imaging; radioactive pharmaceutical preparations for in vivo diagnostics and therapeutic use; pharmaceutical preparations for the prevention of disorders of the cardio-vascular system; pharmaceutical preparations for the treatment of cardiovascular disease; drug delivery agents in the form of biologics, capsule, tablet; drug delivery agents that facilitate the delivery of pharmaceutical preparations; diagnostic agents for medical purposes; pharmaceutical preparations for the prevention of inflammatory disorders; pharmaceutical preparations for the treatment of inflammatory diseases; contrast media for use in medical imaging; biological preparations for medical or veterinary purposes, namely, for the treatment of cancer; diagnostic reagents for medical or veterinary purposes; diagnostic preparations for medical or veterinary purposes; in vitro diagnostic preparations for medical purposes; antibodies for medical purposes; Pharmaceutical preparations for oncology and precision medicine, cancer; radioisotope markers for therapeutic or diagnostic use

Cell separation research services; development of cell therapy products; drug discovery services; research to develop new products in the field of oncology and precision medicine, cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs; Pharmaceutical drug development; pharmaceutical research services; consultancy relating to pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical drug development services; consultancy pertaining to pharmacology; medicine research; stem cell research services; DNA analysis for scientific research purposes; consultation and providing information in the field of biomedicine research and development; research relating to crude drugs; biochemical analysis; clinical research in the field of medicine; scientific research services for medical purposes

Filing History

LIMITATION OF GOODS RECEIVED FROM IB
Sep 5, 2025 LIMG
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 13, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 13, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 27, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 27, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2024 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 17, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 31, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jul 31, 2024 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 11, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 11, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 22, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2024 CNSA
ASSIGNED TO EXAMINER
Apr 8, 2024 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 28, 2024 TEME
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 28, 2024 TROA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 28, 2024 CRFA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 26, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 26, 2024 COAR
REFUSAL PROCESSED BY IB
Oct 25, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 2, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 2, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 20, 2023 RFCR
NON-FINAL ACTION WRITTEN
Sep 19, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 12, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 7, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 2, 2023 REPR